Table of Content

1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentations
1.3. Research Methodology
1.4. Frequently Asked Answered
1.5 Chapter Outlines

2. EXECUTIVE SUMMARY
2.1 Chapter Overview

3. INTRODUCTION
3.1. Chapter Overview
3.2. Role of Smart Labels in the Healthcare Sector
3.2.1 Types of Smart Labels
3.2.1.1. Radio Frequency Identification Device (RFID)
3.2.1.2. Near-Field Communication (NFC)
3.2.1.3. Internet of Things (IoT)
3.2.2. Need for Smart Labels in the Healthcare Sector
3.2.3. Advantages of Using Smart Labels in Healthcare Sector
3.3. Roadblocks and Challenges Associated with the Adoption of Smart Labels
3.4. Adoption of Smart Labels in the Healthcare Sector
3.4.1. Key Drivers for Adoption of Smart Labels
3.5. Future Outlook

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Smart Pharmaceutical and Healthcare Label Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Company Size and Location of Headquarters
4.2.5. Analysis by Type of Technology
4.2.6. Analysis by Company Size and Type of Technology
4.2.7. Analysis by Type of RFID Frequency Band
4.2.8. Analysis by Area(s) of Application
4.2.9. Analysis by Company Size and Area(s) of Application
4.2.10. Analysis by Type of Technology and Area(s) of Application

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions / Key parameter
5.3. Methodology
5.3.1. Smart Pharmaceutical and Healthcare Label Providers based in North America
5.3.2. Smart Pharmaceutical and Healthcare Label Providers based in Europe
5.3.3. Smart Pharmaceutical and Healthcare Label Providers based in Asia-Pacific
5.4. Company Competitiveness Analysis: Benchmarking the Capabilities of Leading Players

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. CCL Industries
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Area(s) of Application
6.2.4. Recent Developments and Future Outlook
6.3. Schreiner
6.3.1. Company Overview
6.3.2. Area(s) of Application
6.3.3. Recent Developments and Future Outlook
6.4. Datalogic
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Area(s) of Application
6.4.4. Recent Developments and Future Outlook
6.5. Tadbik
6.5.1. Company Overview
6.5.2. Area(s) of Application
6.5.3. Recent Developments and Future Outlook
6.6. SATO Asia Pacific
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Area(s) of Application
6.6.4. Recent Developments and Future Outlook
6.7. Invengo
6.7.1. Company Overview
6.7.2. Area(s) of Application
6.7.3. Recent Developments and Future Outlook
6.8. Intellhydro Technology
6.8.1. Company Overview
6.8.2. Area(s) of Application
6.8.3. Recent Developments and Future Outlook
6.9. RFiD Discovery
6.9.1. Company Overview
6.9.2. Area(s) of Application
6.9.3. Recent Developments and Future Outlook
6.10. ID Tech Solutions
6.10.1. Company Overview
6.10.2. Area(s) of Application
6.10.3. Recent Developments and Future Outlook

7. PATENT ANALYSIS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. Smart Pharmaceutical and Healthcare Labels: Patent Analysis
7.3.1. Analysis by Publication Year
7.3.2. Analysis by Publication Year and Type of Patent
7.3.3. Analysis by CPC Code
7.3.4. Analysis by Type of Applicant
7.3.5. Analysis by Geography
7.3.6. Analysis by Emerging Focus Areas
7.3.7. Leading Industry Players: Analysis by Number of Patents
7.4. Smart Pharmaceutical and Healthcare Labels: Patent Benchmarking Analysis
7.4.1. Analysis by Patent Characteristics
7.5. Smart Pharmaceutical and Healthcare Labels: Patent Valuation Analysis

8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Smart Pharmaceutical and Healthcare Labels: Recent Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Most Active Players: Analysis by Number of Partnerships
8.3.4. Regional Analysis
8.3.4.1. Local and International Agreements
8.3.4.2. Intercontinental and Intracontinental Agreements

9. BLUE OCEAN STRATEGY
9.1. Chapter Overview
9.2. Overview of Blue Ocean Strategy
9.2.1 Red Ocean
9.2.2 Blue Ocean
9.2.3 Comparison of Red Ocean Strategy and Blue Ocean Strategy
9.2.4. Smart Pharmaceuticals and Healthcare Labels: Blue Ocean Strategy and Shift Tools
9.2.4.1. Value Innovation
9.2.4.2. Strategy Canvas
9.2.4.3. Four Action Framework
9.2.4.4. Eliminate-Raise-Reduce-Create (ERRC) Grid
9.2.4.5. Six Path Framework
9.2.4.6. Pioneer-Migrator-Settler (PMS) Map
9.2.4.7. Three Tiers of Noncustomers
9.2.4.8. Sequence of Blue Ocean Strategy
9.2.4.9. Buyer Utility Map
9.2.4.10. The Price Corridor of the Mass
9.2.4.11. Four Hurdles to Strategy Execution
9.2.4.12. Tipping Point Leadership
9.2.4.13. Fair Process
9.3. Concluding Remarks

10. MARKET SIZING AND OPPORTUNITY ANALYSIS
10.1. Chapter Overview
10.2. Key Assumptions and Methodology
10.3. Global Smart Pharmaceutical and Healthcare Labels Market, 2022-2035
10.4. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Technology, 2022-2035
10.4.1. Smart Pharmaceutical and Healthcare Labels Market for RFID, 2022-2035
10.4.2. Smart Pharmaceutical and Healthcare Labels Market for NFC, 2022-2035
10.4.3. Smart Pharmaceutical and Healthcare Labels Market for Other Technologies, 2022-2035
10.5. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Packaging, 2022-2035
10.5.1. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Primary Packaging, 2022-2035
10.5.1.1. Smart Pharmaceutical and Healthcare Labels Market for Vials, 2022-2035
10.5.1.2. Smart Pharmaceutical and Healthcare Labels Market for Syringes, 2022-2035
10.5.1.3. Smart Pharmaceutical and Healthcare Labels Market for Cartridges, 2022-2035
10.5.1.4. Smart Pharmaceutical and Healthcare Labels Market for Ampoules, 2022-2035
10.5.1.5. Smart Pharmaceutical and Healthcare Labels Market for Bottles, 2022-2035
10.5.1.6. Smart Pharmaceutical and Healthcare Labels Market for Blister Packs, 2022-2035
10.5.2. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Secondary Packaging, 2022-2035
10.5.2.1. Smart Pharmaceutical and Healthcare Labels Market for Boxes, 2022-2035
10.5.2.2. Smart Pharmaceutical and Healthcare Labels Market for Cartons, 2022-2035
10.5.2.3. Smart Pharmaceutical and Healthcare Labels Market for Pouches, 2022-2035
10.6. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Geography, 2022-2035
10.6.1. Smart Pharmaceutical and Healthcare Labels Market in North America, 2022-2035
10.6.2. Smart Pharmaceutical and Healthcare Labels Market in Europe, 2022-2035
10.6.3. Smart Pharmaceutical and Healthcare Labels Market in Asia-Pacific, 2022-2035
10.6.4. Smart Pharmaceutical and Healthcare Labels Market in MENA, 2022-2035
10.6.5. Smart Pharmaceutical and Healthcare Labels Market in Latin America, 2022-2035
11. SWOT ANALYSIS
11.1. Chapter Overview
11.2. Strengths
11.3. Weaknesses
11.4. Opportunities
11.5. Threats
11.6. Comparison of SWOT Factors
12. CONCLUDING REMARKS
13. APPENDIX I: TABULATED DATA
14. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS